Correlation Between Cyteir Therapeutics and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Enliven Therapeutics, you can compare the effects of market volatilities on Cyteir Therapeutics and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Enliven Therapeutics.
Diversification Opportunities for Cyteir Therapeutics and Enliven Therapeutics
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cyteir and Enliven is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Cyteir Therapeutics and Enliven Therapeutics
Considering the 90-day investment horizon Cyteir Therapeutics is expected to under-perform the Enliven Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cyteir Therapeutics is 5.79 times less risky than Enliven Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Enliven Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 1,657 in Enliven Therapeutics on February 19, 2024 and sell it today you would earn a total of 647.00 from holding Enliven Therapeutics or generate 39.05% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 31.25% |
Values | Daily Returns |
Cyteir Therapeutics vs. Enliven Therapeutics
Performance |
Timeline |
Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Enliven Therapeutics |
Cyteir Therapeutics and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cyteir Therapeutics and Enliven Therapeutics
The main advantage of trading using opposite Cyteir Therapeutics and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn TherapeuticsInc | Cyteir Therapeutics vs. C4 TherapeuticsInc | Cyteir Therapeutics vs. Prelude TherapeuticsInc |
Enliven Therapeutics vs. Pfizer Inc | Enliven Therapeutics vs. Nayax | Enliven Therapeutics vs. HP Inc | Enliven Therapeutics vs. GCM Grosvenor |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |